Ankara Etlik City Hospital
Ankara, 06000, Turkey (Türkiye)
Location status: Recruiting
Location contact
Aslı Dönmez, Professor
CONTACT
Elif Şule Özdemir Sezgi, M.D.
CONTACT
NCT Number: NCT07410078
This prospective, three-arm study aims to evaluate the effects of different oral premedication regimens on venipuncture tolerance in pediatric patients undergoing ambulatory surgery. Children aged 4-12 years scheduled for elective day-case procedures will receive oral midazolam alone, midazolam combined with ibuprofen, or midazolam combined with ketamine prior to anesthesia induction. The primary outcome is the proportion of children with well-tolerated venipuncture, assessed using standardized behavioral and pain scales. Secondary outcomes include anxiety levels, venipuncture success parameters, time to successful intravenous access, and parent and anesthesiologist satisfaction. In cases of inadequate premedication or failed venipuncture, a predefined rescue inhalational induction protocol will be applied to ensure patient safety. The study aims to identify clinically effective premedication strategies that may improve cooperation and reduce distress during intravenous cannulation in pediatric ambulatory anesthesia.
Interested in participating?
Request Info4 year–12 year
All sexes
Interventional
Not applicable
Ankara, 06000, Turkey (Türkiye)
Location status: Recruiting
Aslı Dönmez, Professor
CONTACT
Elif Şule Özdemir Sezgi, M.D.
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants in this group will receive oral midazolam approximately 20 minutes before transfer to the operating room. The medication will be administered as a single dose prior to intravenous cannulation. Behavioral and pain-related assessments will be recorded during intravenous cannulation.
Participants in this group will receive oral midazolam and oral ibuprofen approximately 20 minutes before transfer to the operating room. Both medications will be administered as a single dose prior to intravenous cannulation. Behavioral and pain-related assessments will be recorded during intravenous cannulation.
Participants in this group will receive oral midazolam and oral ketamine approximately 20 minutes before transfer to the operating room. Both medications will be administered as a single dose prior to intravenous cannulation. Behavioral and pain-related assessments will be recorded during intravenous cannulation.
Time frame: During intravenous cannulation in the operating room
The proportion of children with well-tolerated venipuncture during intravenous cannulation, assessed using the Children's Fear Scale (CFS), a validated 5-point scale ranging from 0 to 4 (0 = no fear; 4 = extreme fear). Well-tolerated venipuncture is defined as a CFS score < 3 at the time of the venipuncture attempt.
Time frame: Assessed preoperatively before oral premedication and after premedication in the preoperative holding area.
The mYPAS is an observational behavioral scale consisting of five domains (activity, vocalization, emotional expressivity, state of arousal, and use of parents). Scores are calculated using the original weighted scoring algorithm and generate a standardized total score ranging from 23.3 to 100, with higher scores indicating greater anxiety.
Clinically significant anxiety is defined as mYPAS ≥ 30.
Time frame: During intravenous cannulation in the operating room
Pain intensity assessed using the Wong-Baker Faces Pain Rating Scale, a validated 6-face scale scored from 0 to 10:
0 = no pain 10 = worst pain imaginable Higher scores indicate greater pain intensity.
Contact information is provided by the study sponsor or research team.
Aslı Dönmez
CONTACT
Elif Şule Özdemir Sezgi
CONTACT
Diskapi Yildirim Beyazit Education and Research Hospital
Other Gov
A Comparative Evaluation of Oral Premedication Regimens in Pediatric Patients Undergoing Ambulatory Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07524049
Agnosia, Anxiety
Aarau, Canton of Aargau, Switzerland
View Trial DetailsNCT05221671
Anxiety, Anxiety Disorders
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07714785
Confusion, Delirium
Santiago, Región, Chile
View Trial DetailsNCT07675798
Caudal Block, Congenital Abnormalities
Diyarbakır, Eyalet/Yerleşke, Turkey (Türkiye)
View Trial Details